Ampac reported fine chemicals revenues of $36.4m in its Q3 2012 up 18% on 2011, led by strong anti-viral products revenues. The company said its fine chemicals activities returned to profit during the quarter which it attributed to redesigned processes and cost savings initiatives.
Seeking Alpha
Wednesday 15 August 2012
Ampac fine chemicals returns to profit
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment